New PET tracer could spot Hard-to-Find cancers
NCT ID NCT07117214
First seen Jun 13, 2026 · Last updated Jun 13, 2026
Summary
This early-phase study is testing a new radioactive imaging agent called [68Ga]Ga-DWJ155 to see how well it shows up on PET scans in people with advanced breast cancer or advanced non-small cell lung cancer. The goal is to measure how the agent spreads in the body and whether it can help doctors see tumors more clearly. About 36 adults will take part, and the study will also check for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGGroningen, 9728, Netherlands
Conditions
Explore the condition pages connected to this study.